| Summary: | The following paper focuses on developing an investment thesis and a respective value creation strategy for the potential leveraged buyout of DermapharmHolding SE, a German developer, producer, and distributor of niche prescription and over-the-counter pharmaceuticals. Hence, this thesis determines an entry value based on distinguished valuation methods and assesses the value upon exit by creating a business plan that incorporates the proposed value creation strategies to derive potential returns for investors. Qualitatively, this work evaluates potential exit opportunities and highlights the key points to be investigated during a due diligence.
|
|---|